Biosimilars Month in Review: April 2024
The biosimilars month in review reflects ongoing efforts to address key challenges in rheumatic disease treatment.
Source: hcplive.com
Stay updated with breaking news from Increases Awareness. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The biosimilars month in review reflects ongoing efforts to address key challenges in rheumatic disease treatment.
Clinicians advocate for an at-parity approach to biosimilars, in which they, their patients, and the local market would have the freedom to choose the product that best suits their needs.